celsunax
pinax pharma gmbh - az ioflupán (123i) - radionuclide imaging; dementia; movement disorders - diagnosztikai radiofarmakonok - ez a gyógyszer csak diagnosztikai célra használható. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. felnőtt betegeknél, segít megkülönböztetni valószínű demencia a lewy-testek alzheimer-kór. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
gefitinib stada 250 mg filmtabletta
stada arzneimittel ag - gefitinib -
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunszuppresszánsok - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
axitinib sandoz 1 mg filmtabletta
sandoz hungária kft. - axiti -
axitinib sandoz 5 mg filmtabletta
sandoz hungária kft. - axiti -
saxagliptin pharos 2,5 mg filmtabletta
pharos pharmaceutical oriented services ltd. - saxagliptin hydrochloride -
saxagliptin pharos 5 mg filmtabletta
pharos pharmaceutical oriented services ltd. - saxagliptin hydrochloride -